ALPHA-INTERFERON (ALPHA-IFN) PROTECTS B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS FROM APOPTOTIC CELL-DEATH IN-VITRO

被引:69
作者
PANAYIOTIDIS, P
GANESHAGURU, K
JABBAR, SAB
HOFFBRAND, AV
机构
[1] Department of Haematology, Royal Free Hospital, School of Medicine, London
关键词
CLL; INTERFERON-ALPHA; APOPTOSIS; BCL-2; CORTICOSTEROIDS;
D O I
10.1111/j.1365-2141.1994.tb03269.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-chronic lymphocytic leukaemia cells (CLL) are prone to apoptotic cell death when cultured in vitro. Apoptosis and loss of the bcl-2 protein is prevented in CLL cells cultured in the presence of interleukin-4. In this study we analysed the effects of alpha-IFN on the DNA fragmentation, bcl-2 protein levels and cell survival in purified B-cells from 16 CLL, patients. alpha-IFN (10(3) U/ml) reduced the degree of spontaneous DNA fragmentation of CLL cells after a 30 h culture period (from a mean of 22.2% in control cultures to 10.5%, P<0.01). This inhibition was accompanied by preservation of bcl-2 protein and an increased survival of CLL cells compared to control cultures. In parallel, alpha-IFN inhibited hydrocortisone induced DNA fragmentation in CLL cells. The effects of alpha-IFN on DNA synthesis of CLL cells were variable (in two patients a decrease and in seven an increase in H-3-thymidine uptake) and did not correlate with the effect on DNA fragmentation. In conclusion, our data suggest that alpha-IFN, like IL-4 and gamma-IFN, inhibits apoptosis of CLL cells. These in vitro data indicate that the clinical responses of some CLL patients to alpha-IFN cannot be explained by a direct cytotoxic effect of alpha-IFN on circulating CLL cells. Alternatively, alpha-IFN may inhibit the proliferation of the small fraction of clonegenic CLL progenitors, or interfere with cellular interactions necessary for the survival and growth of CLL cells.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 24 条
  • [11] JEWELL AP, 1992, BLOOD S1, V80, pA192
  • [12] KORSMEYER SJ, 1992, BLOOD, V80, P879
  • [13] Maniatis T., 1982, MOL CLONING
  • [14] MORABITO F, 1993, LEUKEMIA, V7, P366
  • [15] OSTLUND L, 1986, BLOOD, V67, P152
  • [16] PANAYIOTIDIS P, 1993, BRIT J HAEMATOL, V85, P439
  • [17] PANAYIOTIDIS P, 1992, BLOOD S, V80, pA115
  • [18] Panaytotidis P G, 1990, Leuk Lymphoma, V1, P235, DOI 10.3109/10428199009042485
  • [19] PANGALIS GA, 1988, CANCER, V61, P869, DOI 10.1002/1097-0142(19880301)61:5<869::AID-CNCR2820610503>3.0.CO
  • [20] 2-I